A recent study has found that WNK1 and WNK4 positively regulate the Wnt signaling in CRC cells through attenuating the interaction between β-Catenin and the glucose-induced degradation-deficient (GID) complex, a kind of E3 ubiquitin ligase [94]. The gene discussed is WNK1; the disease is colorectal carcinoma.